Douglas K Marks (Faisal Fa'ak, Douglas Marks)

Years Active: 2017-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Douglas K Marks, Nibash Budhathoki, John Kucharczyk, Douglas K Marks, Nina D'Abreo, Maryann Kwa, Magdalena Plasilova, Shubhada Dhage, Phyu Phyu Soe, Daniel Becker, Alexander Hindenburg, Johanna Lee, Megan Winner, Chinyere Okpara, Alison Daly, Darshi Shah, Angela Ramdhanny, Marleen Meyers, Ruth Oratz, James Speyer, Yelena Novik, Freya Schnabel, Simon A Jones, Sylvia Adams
Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 Pandemic. The oncologist 27 (2) (2022)
Douglas K Marks, John Kucharczyk, Pan Kim, Donian I Chyong, Robyn D Gartrell, Yan Lu, Hanina Hibshoosh, Hua Guo, Thomas R Jeffry Evans, Juanita Lopez, Rebecca Kristeleit, Eileen Connolly, Yvonne Saenger, Kevin Kalinsky
Quantitative Multiplex Immunofluorescence Evaluation of the Tumor Microenvironment in Pretreatment Tumors of Patients with Metastatic Breast Cancer and Serous Ovarian Carcinoma Treated with Liposomal Eribulin. Cancer investigation 39 (6-7) (2021)
Evan Rosenbaum, Douglas K Marks, Shahzad Raza
Diagnosis and management of neuropathies associated with plasma cell dyscrasias. Hematological oncology 36 (1) (2017)

Douglas K Marks.css-eqlu8i{font-size:small;padding-left:4px;} (Faisal Fa'ak, Douglas Marks)